Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical trial of COVID-2019 and quadrivalent seasonal influenza combined vaccine in USA

Next Previous
X
Search
Trial Profile

Clinical trial of COVID-2019 and quadrivalent seasonal influenza combined vaccine in USA

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 24 Jun 2021

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs COVID-2019-quadrivalent seasonal influenza combined vaccine-Medigen Vaccine Biologics/Vaxess Technologies (Primary)
  • Indications COVID 2019 infections; Influenza virus infections
  • Focus Adverse reactions; First in man; Proof of concept

    • Most Recent Events

    • 22 Apr 2021 According to a Vaxess Technologies media release, the company will file IND within a year and trial is expected to start in the first half of 2022.
    • 22 Apr 2021 According to a Vaxess Technologies media release, the company was awarded a Commercialization Readiness Program (CRP) grant from the National Institute of Allergy and Infectious Diseases (NIAID grant number SB1AI164584), a part of the U.S. National Institutes of Health (NIH).
    • 22 Apr 2021 According to a Vaxess Technologies media release, the CRP grant will be used to advance the commercialization of the MIMIX technology via CMC activities including design and quality control systems, clinical lot manufacturing, and continued engagement with regulatory stakeholders in preparation for a Phase I clinical trial.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top